Beijing Molecule Science and Technology Co., Ltd.
Records under this name other than the patents Beijing Molecule Science and Technology Co., Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.
Showing 1 to 9 of 9 · Back to Beijing Molecule Science and Technology Co., Ltd.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,544,687 | Substituted α-piperazinyl phenylpropionic acid derivatives as hPPAR α and/or hPPAR γ agonists Term ended Term ended May 28, 2025 · USPTO record | Term ended | Term ended May 28, 2025 | USPTO record |
| US 8,030,323 | Pyrazole carboxamide derivatives, pharmaceutical compositions and its preparation Lapsed on the fee record Ended Oct 4, 2023 · USPTO record | Lapsed on the fee record | Ended Oct 4, 2023 | USPTO record |
| US 8,420,626 | Arene connected polyamine macrocyclic derivatives, preparation methods and pharmaceutical uses thereof Lapsed on the fee record Ended Apr 16, 2021 · USPTO record | Lapsed on the fee record | Ended Apr 16, 2021 | USPTO record |
| US 8,338,616 | Thiazoliums and their use for treating protein aging associated diseases Lapsed on the fee record Ended Dec 25, 2020 · USPTO record | Lapsed on the fee record | Ended Dec 25, 2020 | USPTO record |
| US 8,329,902 | Optically pure dihydropyrimidine compounds and their uses for the preparation of a medicament for treatment and prevention of viral diseases Lapsed on the fee record Ended Dec 11, 2020 · USPTO record | Lapsed on the fee record | Ended Dec 11, 2020 | USPTO record |
| US 8,188,091 | Tetrahydroquinazoline compounds and their use in preparing medicaments for treating and preventing virosis Lapsed on the fee record Ended May 29, 2020 · USPTO record | Lapsed on the fee record | Ended May 29, 2020 | USPTO record |
| US 8,173,643 | N-substituted thiomorpholine derivatives as the inhibitors of dipeptidyl peptidase IV and the pharmaceutical uses thereof Lapsed on the fee record Ended May 8, 2020 · USPTO record | Lapsed on the fee record | Ended May 8, 2020 | USPTO record |
| US 8,168,642 | Dihydropyrimidine compounds and their uses in preparation of medicaments for treating and preventing antiviral diseases Lapsed on the fee record Ended May 1, 2020 · USPTO record | Lapsed on the fee record | Ended May 1, 2020 | USPTO record |
| US 8,106,196 | Dihydropyrimidine compounds and their uses in manufacture of a medicament for treatment and prevention of viral diseases Lapsed on the fee record Ended Jan 31, 2020 · USPTO record | Lapsed on the fee record | Ended Jan 31, 2020 | USPTO record |